Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: The LIFE Study

被引:15
|
作者
Ariansen, Inger [1 ]
Reims, Henrik M. [2 ]
Gjesdal, Knut [1 ,3 ]
Olsen, Michael Hecht [4 ]
Ibsen, Hans [5 ]
Devereux, Richard B. [6 ]
Okin, Peter M. [6 ]
Kjeldsen, Sverre E. [1 ,3 ]
Dahlof, Bjorn [7 ]
Wachtell, Kristian [8 ]
机构
[1] Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway
[2] Univ Oslo, Ulleval Hosp, Dept Pathol, Oslo, Norway
[3] Univ Oslo, Oslo, Norway
[4] Glostrup Univ Hosp, Dept Internal Med, Copenhagen, Denmark
[5] Holbaek Cent Hosp, Div Cardiol, Holbaek, Denmark
[6] Weill Cornell Med Coll, Greenberg Div Cardiol, New York, NY USA
[7] Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden
[8] Univ Copenhagen, Rigshosp, Ctr Heart, Dept Cardiol, DK-2100 Copenhagen, Denmark
关键词
arrhythmia; Cornell voltage-duration product; ethanol; Sokolow-Lyon; HEART-RATE-VARIABILITY; END-POINT REDUCTION; LOSARTAN INTERVENTION; ADRENERGIC ACTIVITY; CARDIAC-RHYTHM; CONSUMPTION; MEN; METAANALYSIS; ATENOLOL; COHORT;
D O I
10.3109/08037051.2011.622978
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background. The incidence of new-onset atrial fibrillation (AF) is increased by uncontrolled hypertension, and antihypertensive treatment reduces new-onset AF. However, it is unclear whether alcohol intake and smoking influence the risk of new-onset AF during antihypertensive treatment. Methods. In the Losartan Intervention F or Endpoint reduction in Hypertension (LIFE) study, a double-blinded, randomized, parallel-group study, 9193 hypertensive patients with electrocardiogram (ECG)-documented left ventricular hypertrophy (LVH), randomized to once-daily losartan- or atenolol-based antihypertensive therapy were followed for a mean of 4.8 years. At baseline, 8831 patients (54% women, mean age 67 years, mean blood pressure 174/98 mmHg after placebo run-in) had neither a history of AF nor AF on ECG, and they were thus at risk of developing this condition during the study. Results. New-onset AF occurred in 353 (4%) patients. Univariate Cox analyses showed that intake of alcohol > 10 units/week compared with less or no alcohol intake predicted new-onset AF (Hazard ratio, HR = 1.60 [95% CI 1.02-2.51], p = 0.043). Multivariate Cox regression analysis showed that intake of alcohol > 10 units/week predicted new-onset AF (p = 0.010) independently of most other univariate predictors, except when also baseline serum cholesterol, serum potassium and urinary albumin/creatinine ratio were included in the model (HR = 1.60 [95% CI 0.94-2.72], p = 0.081). Impact of smoking was not significant in Cox univariate or multivariate analyses, and there were no significant interactions between high alcohol intake and either smoking or gender on the risk of getting AF. Conclusions. Up to 10 drinks of alcohol per week appears to be safe with respect to the risk for AF in hypertensive patients with LVH. Our data suggest that alcohol intake above this level may be marginally deleterious, while no effect of smoking on risk of AF was detected in hypertensive patients with LVH.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 50 条
  • [1] Relationship of Sudden Cardiac Death to New-Onset Atrial Fibrillation in Hypertensive Patients With Left Ventricular Hypertrophy
    Okin, Peter M.
    Bang, Casper N.
    Wachtell, Kristian
    Hille, Darcy A.
    Kjeldsen, Sverre E.
    Dahloef, Bjoern
    Devereux, Richard B.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (02) : 243 - 251
  • [2] In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study
    Wachtell, Kristian
    Gerdts, Eva
    Aurigemma, Gerard P.
    Boman, Kurt
    Dahlof, Bjorn
    Nieminen, Markku S.
    Olsen, Michael Hecht
    Okin, Peter M.
    Palmieri, Vittorio
    Rokkedal, Jens E.
    Devereux, Richard B.
    BLOOD PRESSURE, 2010, 19 (03) : 169 - 175
  • [3] Serum Uric Acid Is Associated With New-Onset Diabetes in Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Study
    Wiik, Benedicte P.
    Larstorp, Anne C. K.
    Hoieggen, Aud
    Kjeldsen, Sverre E.
    Olsen, Michael Hecht
    Ibsen, Hans
    Lindholm, Lars
    Dahlof, Bjorn
    Devereux, Richard B.
    Okin, Peter M.
    Wachtell, Kristian
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (08) : 845 - 851
  • [4] Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation
    Okin, Peter M.
    Gerdts, Eva
    Wachtell, Kristian
    Oikarinen, Lasse
    Nieminen, Markku S.
    Dahlof, Bjorn
    Devereux, Richard B.
    JOURNAL OF HYPERTENSION, 2010, 28 (07) : 1534 - 1540
  • [5] Sex Differences in Atrial Fibrillation and Associated Complications in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study
    Feinberg, Joshua B.
    Nielsen, Emil E.
    Kjeldsen, Sverre E.
    Devereux, Richard B.
    Gerdts, Eva
    Wachtell, Kristian
    Olsen, Michael H.
    AMERICAN JOURNAL OF HYPERTENSION, 2023, 36 (10) : 536 - 541
  • [6] Association of Pulse Pressure With New-Onset Atrial Fibrillation in Patients With Hypertension and Left Ventricular Hypertrophy The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study
    Larstorp, Anne Cecilie K.
    Ariansen, Inger
    Gjesdal, Knut
    Olsen, Michael H.
    Ibsen, Hans
    Devereux, Richard B.
    Okin, Peter M.
    Dahlof, Bjorn
    Kjeldsen, Sverre E.
    Wachtell, Kristian
    HYPERTENSION, 2012, 60 (02) : 347 - +
  • [7] Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study)
    Gerdts, Eva
    Cramariuc, Dana
    de Simone, Giovanni
    Wachtell, Kristian
    Dahlof, Bjorn
    Devereux, Richard B.
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2008, 9 (06): : 809 - 815
  • [8] On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy
    Okin, Peter M.
    Hille, Darcy A.
    Wachtell, Kristian
    Kjeldsen, Sverre E.
    Julius, Stevo
    Devereux, Richard B.
    BLOOD PRESSURE, 2020, 29 (05) : 319 - 326
  • [9] Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study
    Gerdts, E.
    Okin, P. M.
    Omvik, P.
    Wachtell, K.
    Dahlof, B.
    Hildebrandt, P.
    Nieminen, M. S.
    Devereux, R. B.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (05) : 306 - 312
  • [10] Electrocardiographic left atrial abnormalities and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy
    Okin, Peter M.
    Kamel, Hooman
    Kjeldsen, Sverre E.
    Devereux, Richard B.
    JOURNAL OF HYPERTENSION, 2016, 34 (09) : 1831 - 1837